Archive - March 2018
Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults with Type 1 Diabetes
FDA Advisory Committee Votes in Favor of Lucemyra (lofexidine) for the Mitigation of Opioid Withdrawal Symptoms
Lords call for clarity on EU healthcare deal
Six new therapies backed for EU approval
May backs new funding plan for NHS
Testosterone Therapy Does Not Increase Estrogen Levels In Transgender Men, Study Finds
Mylan Introduces Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) Triple Combo Once-Daily HIV Treatment in the U.S.
Feelings Of Embarrassment Are Countered By Taking An Observer’s Perspective